Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Sarcoma × durvalumab × Clear all

Phase

Status

Completed 5 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 41 Lung Neoplasms 19 Carcinoma, Hepatocellular 15 Breast Neoplasms 14 Small Cell Lung Carcinoma 12 Urinary Bladder Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 7 Liver Neoplasms 7 Pancreatic Neoplasms 5 Ovarian Neoplasms 5 Neoplasms 5 Neoplasm Metastasis 5 Cholangiocarcinoma 5 Carcinoma 5 Biliary Tract Neoplasms 5 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 4 Melanoma 4 Endometrial Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Squamous Cell 4 Carcinoma, Renal Cell 4 Prostatic Neoplasms 3 Neoplasms by Site 3 Gallbladder Neoplasms 3 Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Turcot syndrome 2 Thyroid Neoplasms 2

Interventions

Nivolumab 10 pembrolizumab 9 Radiotherapy 9 Magnetic Resonance Spectroscopy 9 Specimen Handling 8 Doxorubicin 8 Cyclophosphamide 7 Biopsy 7 X-Rays 6 Ipilimumab 6 Phantoms, Imaging 5 talimogene laherparepvec 4 Radiation 4 Nuclear Medicine Department, Hospital 4 selpercatinib 3 pazopanib 3 palbociclib 3 cabozantinib 3 Standard of Care 3 Sirolimus 3 Ifosfamide 3 Bevacizumab 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 olaparib 2 liposomal doxorubicin 2 larotrectinib 2 ivosidenib 2 fludarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03784014 2025-12-11

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Active not recruiting

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡